{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T00:25:36Z","timestamp":1780100736051,"version":"3.54.0"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2013,9,3]],"date-time":"2013-09-03T00:00:00Z","timestamp":1378166400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1007\/s11011-013-9433-z","type":"journal-article","created":{"date-parts":[[2013,9,2]],"date-time":"2013-09-02T05:01:07Z","timestamp":1378098067000},"page":"687-696","source":"Crossref","is-referenced-by-count":46,"title":["N-acetyl cysteine reverses social isolation rearing induced changes in cortico-striatal monoamines in rats"],"prefix":"10.1007","volume":"28","author":[{"given":"Marisa","family":"M\u00f6ller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan L.","family":"Du Preez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francois P.","family":"Viljoen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Berk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian H.","family":"Harvey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,9,3]]},"reference":[{"key":"9433_CR1","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0165-0173(99)00046-6","volume":"31","author":"GK Aghajanian","year":"2000","unstructured":"Aghajanian GK, Marek GJ (2000) Serotonin model of schizophrenia: emerging role of glutamate mechanisms. Brain Res Rev 31:302\u2013312","journal-title":"Brain Res Rev"},{"key":"9433_CR2","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.neuint.2012.07.024","volume":"61","author":"CO Arent","year":"2012","unstructured":"Arent CO, R\u00e9us GZ, Abelaira HM, Ribeiro KF, Steckert AV, Mina F et al (2012) Synergist effects of n-acetylcysteine and deferoxamine treatment on behavioral and oxidative parameters induced by chronic mild stress in rats. Neurochem Int 61:1072\u201380","journal-title":"Neurochem Int"},{"key":"9433_CR3","doi-asserted-by":"crossref","first-page":"11729","DOI":"10.1073\/pnas.1834314100","volume":"100","author":"MV Avshalumov","year":"2003","unstructured":"Avshalumov MV, Rice ME (2003) Activation ofATP-sensitive K\u2009+\u2009(K(ATP)) channels by H2O2 underlies glutamate-dependent inhibition of striatal dopamine release. Proc. Natl Acad Sci USA 100:11729\u201311734","journal-title":"Natl Acad Sci USA"},{"key":"9433_CR4","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.biopsych.2008.04.022","volume":"64","author":"M Berk","year":"2008","unstructured":"Berk M, Copolov DL, Dean O, Lu K, Jeavons S, Schapkaitz I, Anderson-Hunt M, Bush AI (2008a) N-Acetyl cysteine for depressive symptoms in bipolar disorder\u2014a double-blind randomized placebo-controlled trial. Biol Psychiatry 64:468\u2013475","journal-title":"Biol Psychiatry"},{"key":"9433_CR5","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.biopsych.2008.03.004","volume":"64","author":"M Berk","year":"2008","unstructured":"Berk M, Copolov DL, Dean O, Lu K, Jeavons S, Schapkaitz I, Anderson-Hunt M, Judd F, Katz F, Katz P et al (2008b) N-Acetyl cysteine as a glutathione precursor for schizophrenia\u2014a double-blind, randomized, placebo-controlled trial. Biol Psychiatry 64:361\u2013368","journal-title":"Biol Psychiatry"},{"key":"9433_CR6","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.jad.2011.06.005","volume":"135","author":"M Berk","year":"2011","unstructured":"Berk M, Dean O, Cotton SM, Gama CS, Kapczinski F, Fernandes BS, Kohlmann K, Jeavons S, Hewitt K, Allwang C, Cobb H, Bush AI, Dodd S, Malhi GS (2011) The efficacy of n-acetylcysteine as an adjunctive treatment in bipolar depression: an open label trial. J Affect Disord 135:389\u2013394","journal-title":"J Affect Disord"},{"key":"9433_CR7","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.tips.2013.01.001","volume":"34","author":"M Berk","year":"2013","unstructured":"Berk M, Malhi GS, Gray LJ, Dean OM (2013) The promise of N-acetylcysteine in neuropsychiatry. Trends Pharmacol Sci 34:167\u2013177","journal-title":"Trends Pharmacol Sci"},{"key":"9433_CR8","doi-asserted-by":"crossref","first-page":"792","DOI":"10.2174\/187152711798072392","volume":"10","author":"HG Bernstein","year":"2011","unstructured":"Bernstein HG, Keilhoff G, Steiner J, Dobrowolny H, Bogerts B (2011) Nitric oxide and schizophrenia: present knowledge and emerging concepts of therapy. CNS Neurol Disord Drug Targets 10:792\u2013807","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"9433_CR9","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1080\/13651500701388310","volume":"11","author":"P Blier","year":"2007","unstructured":"Blier P, El Mansari M (2007) The importance of serotonin and noradrenaline in anxiety. Int J Psychiatry Clin Pract 11:16\u201323","journal-title":"Int J Psychiatry Clin Pract"},{"key":"9433_CR10","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.bbr.2008.10.036","volume":"198","author":"JC Brenes","year":"2009","unstructured":"Brenes JC, Fornaguera J (2009) The effect of chronic fluoxetine on social isolation-induced changes on sucrose consumption, immobility behavior, and on serotonin and dopamine function in hippocampus and ventral striatum. Behav Brain Res 198:199\u2013205","journal-title":"Behav Brain Res."},{"key":"9433_CR11","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.biopsych.2012.09.020","volume":"73","author":"JH Cabungcal","year":"2012","unstructured":"Cabungcal JH, Steullet P, Kraftsik R, Cuenod M, Do KQ (2012) Early-life insults impair parvalbumin interneurons via oxidative stress: Reversal by N-acetylcysteine. Biol Psychiatry 73:574\u201382","journal-title":"Biol Psychiatry"},{"key":"9433_CR12","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1146\/annurev.pharmtox.41.1.237","volume":"41","author":"A Carlsson","year":"2001","unstructured":"Carlsson A, Waters N, Holm-Waters S, Tedroff J, Nilsson M, Carlsson ML (2001) Interactions between monoamines, glutomate, and GABA in schizophrenia: New evidence. Ann Rev Pharmacol Toxicol 41:237\u2013260","journal-title":"Ann Rev Pharmacol Toxicol"},{"key":"9433_CR13","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1037\/0033-2909.124.1.3","volume":"124","author":"BF Chorpita","year":"1998","unstructured":"Chorpita BF, Barlow DH (1998) The development of anxiety: the role of control in the early environment. Psychol Bull 124:3\u201321","journal-title":"Psychol Bull"},{"key":"9433_CR14","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.psyneuen.2010.09.012","volume":"36","author":"R Dantzer","year":"2011","unstructured":"Dantzer R, O\u2019Connor JC, Lawson MA, Kelley KW (2011) Inflammation-associated depression: from serotonin to kynurenine. Psychoneuroendocrinology 36:426\u2013436","journal-title":"Psychoneuroendocrinology"},{"key":"9433_CR15","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.2174\/092986709788803060","volume":"16","author":"OM Dean","year":"2009","unstructured":"Dean OM, van den Buuse M, Bush AI (2009) A role for glutathione in the pathophysiology of bipolar disorder and schizophrenia? Animal models and relevance to clinical practice. Curr Med Chem 16:2965\u201376","journal-title":"Curr Med Chem"},{"key":"9433_CR16","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1503\/jpn.100057","volume":"36","author":"OM Dean","year":"2011","unstructured":"Dean OM, Giorlando F, Berk M (2011) N-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action. J Psychiatry Neurosci 36:78\u201386","journal-title":"J Psychiatry Neurosci."},{"key":"9433_CR17","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1517\/14728220802517901","volume":"8","author":"S Dodd","year":"2008","unstructured":"Dodd S, Dean O, Copolov DL, Malhi GS, Berk M (2008) N-acetylcysteine for antioxidant therapy: Pharmacology and clinical utility. Expert Opin Biol Ther 8:1955\u20131962","journal-title":"Expert Opin Biol Ther"},{"key":"9433_CR18","first-page":"608","volume":"39","author":"II Galynker","year":"1998","unstructured":"Galynker II, Cai J, Ongseng F, Finestone H, Dutta E, Serseni D (1998) Hypofrontality and negative symptoms in major depressive disorder. J Nucl Med 39:608\u2013612","journal-title":"J Nucl Med"},{"key":"9433_CR19","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.mito.2008.05.001","volume":"8","author":"A Garcia-Cazorla","year":"2008","unstructured":"Garcia-Cazorla A, Duarte S, Serrano M, Nascimento A, Ormazabal A, Carrilho I et al (2008) Mitochondrial diseases mimicking neurotransmitter defects. Mitochondrion 8:273\u2013278","journal-title":"Mitochondrion"},{"key":"9433_CR20","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0165-0327(95)00078-X","volume":"37","author":"MJ Garvey","year":"1996","unstructured":"Garvey MJ, Tuason VB (1996) Low levels of MHPG in depressive spectrum patients. J Affect Disord 37:103\u2013108","journal-title":"J Affect Disord"},{"key":"9433_CR21","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1017\/S1461145711000617","volume":"14","author":"JW Gawryluk","year":"2011","unstructured":"Gawryluk JW, Wang J, Andreazza AC, Shao L, Yatham LM, Young LT (2011) Prefrontal cortex glutathione S-transferase levels in patients with bipolar disorder, major depression and schizophrenia. Int J Neuropsychopharmacol 14:1069\u20131074","journal-title":"Int J Neuropsychopharmacol"},{"key":"9433_CR22","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1001\/archgenpsychiatry.2009.60","volume":"66","author":"JE Grant","year":"2009","unstructured":"Grant JE, Odlaug BL, Kim SW (2009) N-acetylcysteine, a glutamate modulator, in the treatment of trichotillomania: a double-blind, placebo-controlled study. Arch Gen Psychiatry 66:756\u2013763","journal-title":"Arch Gen Psychiatry"},{"key":"9433_CR23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0074-7742(06)78001-1","volume":"78","author":"O Guillin","year":"2007","unstructured":"Guillin O, Abi-Dargham A, Laruelle M (2007) Neurobiology of dopamine in schizophrenia. Int Rev Neurobiol 78:1\u201339","journal-title":"Int Rev Neurobiol"},{"key":"9433_CR24","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1566-2772(03)00020-3","volume":"3","author":"V Haroutunian","year":"2003","unstructured":"Haroutunian V, Dracheva S, Davis KL (2003) Neurobiology of glutamatergic abnormalities in schizophrenia. Clin Neurosci Res 3:67\u201376","journal-title":"Clin Neurosci Res"},{"key":"9433_CR25","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1023\/B:NERE.0000029560.14262.39","volume":"29","author":"LG Harsing","year":"2004","unstructured":"Harsing LG, Prauda I, Barkoczy J, Matyus P, Juranyi Z (2004) A 5-HT7 heteroreceptor-mediated inhibition of [3H]serotonin release in raphe nuclei slices of the rat: evidence for a serotonergic-glutamatergic interaction. Neurochem Res 29:1487\u20131497","journal-title":"Neurochem Res"},{"key":"9433_CR26","first-page":"661","volume":"89","author":"BH Harvey","year":"1999","unstructured":"Harvey BH, Stein DJ, Emsley RA (1999) The new generation antipsychotics: integrating the neuropathology and pharmacology of schizophrenia. S Afr Med J 89:661\u2013672","journal-title":"S Afr Med J"},{"key":"9433_CR27","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.physbeh.2006.01.033","volume":"87","author":"BH Harvey","year":"2006","unstructured":"Harvey BH, Brand L, Jeeva Z, Stein DJ (2006) Cortical\/hippocampal monoamines, HPA-axis changes and aversive behavior following stress and restress in an animal model of post-traumatic stress disorder. Physiol Behav 87:881\u201390","journal-title":"Physiol Behav"},{"key":"9433_CR28","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1176\/appi.ajp.159.3.480","volume":"159","author":"U Heresco-Levy","year":"2002","unstructured":"Heresco-Levy U, Ermilov M, Shimoni J, Shapira B, Silipo G, Javitt DC (2002) Placebo-controlled trial of D-cycloserine added to conventional neuroleptics, olanzapine, or risperidone in schizophrenia. Am J Psychiatry 159:480\u2013482","journal-title":"Am J Psychiatry"},{"key":"9433_CR29","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.neures.2010.08.007","volume":"68","author":"J Hovattaa","year":"2010","unstructured":"Hovattaa J, Juhila J, Donner J (2010) Oxidative stress in anxiety and comorbid disorders. Neurosci Res 68:261\u2013275","journal-title":"Neurosci Res"},{"key":"9433_CR30","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1093\/schbul\/sbp006","volume":"35","author":"OD Howes","year":"2009","unstructured":"Howes OD, Kapur S (2009) The Dopamine Hypothesis of Schizophrenia: Version III - The Final Common Pathway. Schizophr Bull 35:549\u2013562","journal-title":"Schizophr Bull"},{"key":"9433_CR31","first-page":"157","volume":"62","author":"E Jaffe","year":"1991","unstructured":"Jaffe E, De Frias V, Ibarra C (1991) Changes in basal and stimulated release of endogenous serotonin from different nuclei of rats subjected to two models of depression. Neurosci Lett 62:157\u2013160","journal-title":"Neurosci Lett"},{"key":"9433_CR32","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/npp.1993.32","volume":"8","author":"JN Joyce","year":"1993","unstructured":"Joyce JN, Shane A, Lexow N, Winokur A, Casanova MF, Kleinman JE (1993) Serotonin uptake sites and serotonin receptors are altered in the limbic system of schizophrenics. Neuropsychopharmacology 8:315\u201336","journal-title":"Neuropsychopharmacology"},{"key":"9433_CR33","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1550-2783-2-2-38","volume":"2","author":"C Kerksick","year":"2005","unstructured":"Kerksick C, Willoughby D (2005) The Antioxidant Role of Glutathione and N-Acetyl-Cysteine Supplements and Exercise-Induced Oxidative Stress. J Int Soc Sports Nutr 2:38\u201344","journal-title":"J Int Soc Sports Nutr"},{"key":"9433_CR34","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.euroneuro.2007.11.001","volume":"18","author":"A Krivoy","year":"2008","unstructured":"Krivoy A, Fischel T, Weizman A (2008) The possible involvement of metabotropic glutamate receptors in schizophrenia. Euro Neuropsychopharmacol 18:395\u2013405","journal-title":"Euro Neuropsychopharmacol"},{"key":"9433_CR35","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/1098-2396(20010301)39:3<222::AID-SYN1003>3.0.CO;2-R","volume":"39","author":"U Kr\u00fcgel","year":"2001","unstructured":"Kr\u00fcgel U, Kittner H, Illes P (2001) Mechanisms of adenosine 50-triphosphate-induced dopamine release in the rat nucleus accumbens in vivo. Synapse 39:222\u2013232","journal-title":"Synapse"},{"key":"9433_CR36","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/cbf.940","volume":"20","author":"M Kuloglu","year":"2002","unstructured":"Kuloglu M, Ustundag B, Atmaca M, Canatan H, Tezcan AE, Cinkilinc N (2002) Lipid peroxidation and antioxidant enzyme levels in patients with schizophrenia and bipolar disorder. Cell Biochem Func 20:171\u2013175","journal-title":"Cell Biochem Func"},{"key":"9433_CR37","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/j.pnpbp.2008.07.001","volume":"32","author":"M Kunz","year":"2008","unstructured":"Kunz M, Gama CS, Andreazza AC, Salvador M, Ceres\u00e9r KM, Gomes FA, Belmonte-de-Abreu PS, Berk M, Kapczinski F (2008) Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in different phases of bipolar disorder and in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 32:1677\u20131681","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"9433_CR38","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/sj.npp.1301563","volume":"33","author":"D Lewis","year":"2008","unstructured":"Lewis D, Gonz\u00e1lez-Burgos G (2008) Neuroplasticity of neocortical circuits in schizophrenia. Neuropsychopharmacology 33:141\u2013165","journal-title":"Neuropsychopharmacology"},{"key":"9433_CR39","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1192\/S0007125000292544","volume":"163","author":"JA Lieberman","year":"1993","unstructured":"Lieberman JA (1993) Understanding the mechanism of action of atypical antipsychotic drugs: a review of compounds in use and development. Brit J Psychiatry 163:7\u201318","journal-title":"Brit J Psychiatry"},{"key":"9433_CR40","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1600-0447.2007.01067.x","volume":"116","author":"PH Lysaker","year":"2007","unstructured":"Lysaker PH, Salyers MP (2007) Anxiety symptoms in schizophrenia spectrum disorders: associations with social function, positive and negative symptoms, hope and trauma history. Acta Psychiatr Scand 116:290\u2013298","journal-title":"Acta Psychiatr Scand"},{"key":"9433_CR41","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1590\/S1516-44462011000400011","volume":"33","author":"PV Magalhaes","year":"2011","unstructured":"Magalhaes PV, Dean O, Bush AI, Copolov DL, Malhi GS, Kohlmann K, Jeavons S, Schapkaitz I, Anderson-Hunt M, Berk M (2011) N-acetylcysteine for major depressive episodes in bipolar disorder. Rev Bras Psiquiatr 33:374\u2013378","journal-title":"Rev Bras Psiquiatr"},{"key":"9433_CR42","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.schres.2011.09.020","volume":"133","author":"SL Matheson","year":"2011","unstructured":"Matheson SL, Shepherd AM, Laurens KR, Carr VJ (2011) A systematic metareview grading the evidence for non-genetic risk factors and putative antecedents of schizophrenia. Schizophr Res 133:133\u2013142","journal-title":"Schizophr Res"},{"key":"9433_CR43","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.neuropharm.2010.03.014","volume":"59","author":"EN McNamee","year":"2010","unstructured":"McNamee EN, Griffin EW, Ryan KM, Ryan KJ, Heffernan S, Harkin A, Connor TJ (2010) Noradrenaline acting at beta-adrenoceptors induces expression of IL-1beta and its negative regulators IL-1ra and IL-1RII, and drives an overall anti-inflammatory phenotype in rat cortex. Neuropharmacology 59:37\u201348","journal-title":"Neuropharmacology"},{"key":"9433_CR44","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.pnpbp.2003.09.010","volume":"27","author":"HY Meltzer","year":"2003","unstructured":"Meltzer HY, Li Z, Kaneda Y, Ichikawa J (2003) Serotonin receptors: their key role in drugs to treat schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 27:1159\u20131172","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"9433_CR45","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s00213-009-1504-9","volume":"206","author":"U Meyer","year":"2009","unstructured":"Meyer U, Feldon J (2009) Prenatal exposure to infection: a primary mechanism for abnormal dopaminergic development in schizophrenia. Psychopharmacol 206:587\u201360","journal-title":"Psychopharmacol"},{"key":"9433_CR46","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/nn804","volume":"5","author":"A Meyer-Lindenberg","year":"2002","unstructured":"Meyer-Lindenberg A, Miletich RS, Kohn PD, Esposito G, Carson RE, Quarantelli M, Weinberger DR, Berman KF (2002) Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia. Nat Neurosci 5:267\u201371","journal-title":"Nat Neurosci"},{"key":"9433_CR47","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0306-4522(03)00340-3","volume":"120","author":"E Milusheva","year":"2003","unstructured":"Milusheva E, Sperl\u00e1gh B, Shikova L, Baranyi M, Tretter L, Ad\u00e1m-Vizi V, Vizi ES (2003) Non-synaptic release of [3H]noradrenaline in response to oxidative stress combined with mitochondrial dysfunction in rat hippocampal slices. Neurosci 120:771\u2013781","journal-title":"Neurosci"},{"key":"9433_CR48","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/sj.mp.4001556","volume":"10","author":"S Miyamoto","year":"2005","unstructured":"Miyamoto S, Duncan GE, Marx CE, Lieberman JA (2005) Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs. Mol Psychiatry 10:79\u2013104","journal-title":"Mol Psychiatry"},{"key":"9433_CR49","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.euroneuro.2010.09.006","volume":"21","author":"M M\u00f6ller","year":"2011","unstructured":"M\u00f6ller M, Du Preez JL, Emsley R, Harvey BH (2011) Isolation rearing-induced deficits in sensorimotor gating and social interaction in rats are related to cortico-striatal oxidative stress, and reversed by sub-chronic clozapine administration. Eur Neuropsychopharmacol 21:471\u2013483","journal-title":"Eur Neuropsychopharmacol"},{"key":"9433_CR50","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1016\/j.neuropharm.2012.02.021","volume":"62","author":"M M\u00f6ller","year":"2012","unstructured":"M\u00f6ller M, Du Preez JL, Emsley R, Harvey BH (2012) Social isolation rearing in rats alters plasma tryptophan metabolism and is reversed by sub-chronic clozapine treatment. Neuropharmacology 62:2499\u20132506","journal-title":"Neuropharmacology"},{"key":"9433_CR51","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.bbi.2012.12.011","volume":"30","author":"M M\u00f6ller","year":"2013","unstructured":"M\u00f6ller M, Du Preez JL, Viljoen FP, Berk M, Emsley R, Harvey BH (2013) Social isolation rearing induces mitochondrial, immunological, neurochemical and behavioural deficits in rats, and is reversed by clozapine or N-acetyl cysteine. Brain Behav Immun 30:156\u201367","journal-title":"Brain Behav Immun"},{"key":"9433_CR52","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0920-9964(95)00048-8","volume":"19","author":"S Mukherjee","year":"1996","unstructured":"Mukherjee S, Mahadik SP, Scheffer R, Correntie E, Kelkar H (1996) Impaired antioxidant defence at the onset of psychosis. Schizophr Res 19:19\u201326","journal-title":"Schizophr Res"},{"key":"9433_CR53","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.neuint.2011.05.002","volume":"59","author":"L Musazzi","year":"2011","unstructured":"Musazzi L, Racagni G, Popoli M (2011) Stress, glucocorticoids and glutamate release: effects of antidepressant drugs. Neurochem Int 59:138\u201349","journal-title":"Neurochem Int"},{"key":"9433_CR54","first-page":"851","volume":"11","author":"F Ng","year":"2008","unstructured":"Ng F, Berk M, Dean O, Bush AI (2008) Oxidative stress in psychiatric disorders: evidence base and therapeutic implications. Int J Neuropsychopharmacol 11:851\u2013876","journal-title":"Int J Neuropsychopharmacol"},{"key":"9433_CR55","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1111\/j.1471-4159.2011.07369.x","volume":"118","author":"A Okuno","year":"2011","unstructured":"Okuno A, Fukuwatari T, Shibata K (2011) High tryptophan diet reduces extracellular dopamine release via kynurenic acid production in rat striatum. J Neurochem 118:796\u2013805","journal-title":"J Neurochem"},{"key":"9433_CR56","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1017\/S146114570800967X","volume":"12","author":"JB O\u2019Sullivan","year":"2009","unstructured":"O\u2019Sullivan JB, Ryan KM, Curtin NM, Harkin A, Connor TJ (2009) Noradrenaline reuptake inhibitors limit neuroinflammation in rat cortex following a systemic inflammatory challenge: implications for depression and neurodegeneration. Int J Neuropsychopharmacol 12:687\u201399","journal-title":"Int J Neuropsychopharmacol"},{"key":"9433_CR57","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1365-2826.2008.01701.x","volume":"20","author":"P Pervanidou","year":"2008","unstructured":"Pervanidou P (2008) Biology of post-traumatic stress disorder in childhood and adolescence. J Neuroendocrinol 20:632\u2013638","journal-title":"J Neuroendocrinol"},{"key":"9433_CR58","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0306-4522(03)00122-2","volume":"119","author":"SB Powell","year":"2003","unstructured":"Powell SB, Geyer MA, Preece MA, Pitcher LK, Reynolds GP, Swerdlow NR (2003) Dopamine depletion of the nucleus accumbens reverses isolation-induced deficits in prepulse inhibition in rats. Neurosci 119:233\u201340","journal-title":"Neurosci"},{"key":"9433_CR59","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/sj.mp.4001532","volume":"9","author":"S Prabakaran","year":"2004","unstructured":"Prabakaran S, Swatton J, Ryan MM, Huffaker SJ, Huang JT, Griffin JL et al (2004) Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress. Mol Psychiatry 9:684\u2013697","journal-title":"Mol Psychiatry"},{"key":"9433_CR60","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.neuropharm.2009.12.009","volume":"58","author":"NV Radonji\u0107","year":"2010","unstructured":"Radonji\u0107 NV, Knezevi\u0107 ID, Vilimanovich U (2010) Decreased glutathione levels and altered antioxidant defense in an animal model of schizophrenia: long-term effects of perinatal phencyclidine administration. Neuropharmacology 58:739\u201345","journal-title":"Neuropharmacology"},{"key":"9433_CR61","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/S0278-5846(01)00167-1","volume":"25","author":"O Rilke","year":"2001","unstructured":"Rilke O, Will K, J\u00e4hkel M, Oehler J (2001) Behavioral and neurochemical effects of anpirtoline and citalopram in isolated and group housed mice. Prog Neuro- Psychopharmacol Biol Psychiatry 25:1125\u20131144","journal-title":"Prog Neuro- Psychopharmacol Biol Psychiatry"},{"key":"9433_CR62","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0006-3223(00)00850-7","volume":"48","author":"H Rollema","year":"2000","unstructured":"Rollema H, Lu Y, Schmidt AW, Sprouse JS, Zorn SH (2000) 5-HT(1A) receptor activation contributes to ziprasidone-induced dopamine release in the rat prefrontal cortex. Biol Psychiatry 48:229\u2013237","journal-title":"Biol Psychiatry"},{"key":"9433_CR63","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.biopsych.2009.04.033","volume":"66","author":"S Schiavone","year":"2009","unstructured":"Schiavone S, Sorce S, Dubois-Dauphin M, Jaquet V, Colaianna M, Zotti M, Cuomo V, Trabace L, Krause KH (2009) Involvement of Nox2 in the development of behavioral and pathologic alterations in isolated rats. Biol Psychiatry 66:384\u2013392","journal-title":"Biol Psychiatry"},{"key":"9433_CR64","doi-asserted-by":"crossref","first-page":"e111","DOI":"10.1038\/tp.2012.36","volume":"2","author":"S Schiavone","year":"2012","unstructured":"Schiavone S, Jaquet V, Sorce S, Dubois-Dauphin M, Hultqvist M, B\u00e4ckdahl L et al (2012) NADPH oxidase elevations in pyramidal neurons drive psychosocial stress-induced neuropathology. Transl Psychiatry 2:e111","journal-title":"Transl Psychiatry"},{"key":"9433_CR65","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3389\/fphar.2012.00195","volume":"3","author":"TL Schwartz","year":"2012","unstructured":"Schwartz TL, Sachdeva S, Stahl SM (2012) Glutamate neurocircuitry: theoretical underpinnings in Schizophrenia. Front Pharmacol 3:195","journal-title":"Front Pharmacol"},{"key":"9433_CR66","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/bdra.20623","volume":"88","author":"S Singh","year":"2010","unstructured":"Singh S, Greene RM, Pisano MM (2010) Arsenate-induced apoptosis in murine embryonic maxillary mesenchymal cells via mitochondrial-mediated oxidative injury. Birth Defects Res A Clin Mol Teratol 88:25\u201334","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"9433_CR67","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.pnpbp.2012.06.018","volume":"39","author":"I Smaga","year":"2012","unstructured":"Smaga I, Pomierny B, Krzy\u017canowska W, Pomierny-Chamio\u0142o L, Miszkiel J, Niedzielska E, Og\u00f3rka A, Filip M (2012) N-acetylcysteine possesses antidepressant-like activity through reduction of oxidative stress: Behavioral and biochemical analyses in rats. Prog Neuro-Psychopharmacol Biol Psychiatry 39:280\u2013287","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"9433_CR68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2999(99)00048-5","volume":"370","author":"J Smythies","year":"1999","unstructured":"Smythies J (1999) Redox mechanisms at the glutamate synapse and their significance: a review. Eur J Pharmacol 370:1\u20137","journal-title":"Eur J Pharmacol"},{"key":"9433_CR69","doi-asserted-by":"crossref","first-page":"11317","DOI":"10.1523\/JNEUROSCI.1491-10.2010","volume":"30","author":"S Sorce","year":"2010","unstructured":"Sorce S, Schiavone S, Tucci P, Colaianna M, Jaquet V, Cuomo V et al (2010) The NADPH oxidase NOX2 controls glutamate release: a novel mechanism involved in psychosis-like ketamine responses. J Neurosci 30:11317\u201311325","journal-title":"J Neurosci"},{"key":"9433_CR70","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1017\/S1092852900021015","volume":"12","author":"SM Stahl","year":"2007","unstructured":"Stahl SM (2007) Beyond the dopamine hypothesis to the NMDA glutamate receptor hypofunction hypothesis of schizophrenia. CNS Spectr 12:265\u2013268","journal-title":"CNS Spectr"},{"key":"9433_CR71","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0006-8993(95)01361-X","volume":"708","author":"T Sumiyoshi","year":"1996","unstructured":"Sumiyoshi T, Stockmeier C, Overholser J, Dilley G, Meltzer H (1996) Serotonin-1A receptors are increased in postmortem prefrontal cortex in schizophrenia. Brain Res 708:209\u2013214","journal-title":"Brain Res"},{"key":"9433_CR72","unstructured":"Swanson LW (2004) Brain maps: structure of the rat brain. Elsevier Academic Press"},{"key":"9433_CR73","doi-asserted-by":"crossref","first-page":"62","DOI":"10.2174\/1875397300802010062","volume":"2","author":"JT Ting","year":"2008","unstructured":"Ting JT, Feng G (2008) Glutamatergic synaptic dysfunction and obsessive-compulsive disorder. Curr Chem Genomics 2:62\u201375","journal-title":"Curr Chem Genomics"},{"key":"9433_CR74","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.neuroscience.2009.10.039","volume":"165","author":"C Toua","year":"2010","unstructured":"Toua C, Brand L, M\u00f6ller M, Emsley RA, Harvey BH (2010) The effects of sub-chronic clozapine and haloperidol administration on isolation rearing induced changes in frontal cortical N-methyl-D-aspartate and D1 receptor binding in rats. Neurosci 165:492\u2013499","journal-title":"Neurosci"},{"key":"9433_CR75","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1601-5215.2011.00627.x","volume":"24","author":"L Trabace","year":"2012","unstructured":"Trabace L, Zotti M, Colaianna M, Mg M, Schiavone S, Tucci P, Harvey BH, Wegener G, Cuomo V (2012) Neurochemical differences in two rat strains exposed to social isolation rearing. Acta Neuropsychiatrica 24:286\u2013295","journal-title":"Acta Neuropsychiatrica"},{"key":"9433_CR76","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1399-5618.2009.00717.x","volume":"11","author":"J Wang","year":"2009","unstructured":"Wang J, Shao L, Sun X, Young LT (2009) Increased oxidative stress in the striatum of subjects with bipolar disorder and schizophrenia. Biopolar Disord 11:523\u2013529","journal-title":"Biopolar Disord"},{"key":"9433_CR77","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/jn\/134.3.489","volume":"134","author":"G Wu","year":"2004","unstructured":"Wu G, Fang Y, Yang S, Lupton JR, Turner ND (2004) Glutathione Metabolism and Its Implications for Health. J Nutr 134:489\u2013492","journal-title":"J Nutr"},{"key":"9433_CR78","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.pnpbp.2004.05.033","volume":"28","author":"K Yamamoto","year":"2004","unstructured":"Yamamoto K, Hornykiewicz O (2004) Proposal for a noradrenaline hypothesis of schizophrenia. Prog NeuroPsychopharmacol Biol Psychiatry 28:913\u2013922","journal-title":"Prog NeuroPsychopharmacol Biol Psychiatry"},{"key":"9433_CR79","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.neuint.2010.02.015","volume":"56","author":"M Zum\u00e1rraga","year":"2010","unstructured":"Zum\u00e1rraga M, D\u00e1vila R, Basterreche N, Arrue A, Goienetxea B, Zamalloa MI, Erkoreka L, Bustamante S, Inchausti L, Gonz\u00e1lez-Torres MA, Guim\u00f3n J (2010) Catechol O-methyltransferase and monoamine oxidase A genotypes, and plasma catecholamine metabolites in bipolar and schizophrenic patients. Neurochem Int 56:774\u2013779","journal-title":"Neurochem Int"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-013-9433-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11011-013-9433-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-013-9433-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T14:47:17Z","timestamp":1715957237000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11011-013-9433-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,3]]},"references-count":79,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["9433"],"URL":"https:\/\/doi.org\/10.1007\/s11011-013-9433-z","relation":{},"ISSN":["0885-7490","1573-7365"],"issn-type":[{"value":"0885-7490","type":"print"},{"value":"1573-7365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,3]]}}}